Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Green Energy Origin is a sustainable firm that develops specialty chemicals and battery raw materials for cost effective energy solutions.
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
Convergen develops TrimTAC, a targeted protein degradation platform for treating neurodegenerative diseases.
ChemLex is a chemical synthesis CRO that was founded by Magera Technology.
Infinigence is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools.
ByteDance is a technology company that develops content creation platforms and services.
Shenkepu Industry provides industrial process automation solutions and uses high-end process equipment.
Ronghe Medical is a medical device manufacturer specializing in the design, R&D, production, and sales of high-end medical device systems.
Dexmal is a start-up focusing on embodied intelligence technology.
Vybio is a high-tech enterprise focusing on innovative drug research and development.
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.
Brise Pharma operates in the scientific research and technical service industry.
Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.
WeRide is an autonomous driving company that develops and operates self-driving technologies for transportation services.
Changsen Pharmaceutical is a high-tech enterprise specializing in the research and development of oncology drugs.
Theraheart is a medical device company that offers innovative, minimally invasive solutions for heart failure.
Future Intelligence is a technology startup focused on making human-computer interaction more feasible.
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
Hugemed manufactures of medical devices and provides solutions in the field of endoscopy.
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
Thorough Future helps in integrating cutting-edge technology into medical care, delivering more accurate and efficient diagnostic services.
Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.
VINNO Technology is an international company that provides the fastest medical solutions in every situation.
Qiming Venture Partners has invested in 399 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Qiming Venture Partners's top investment sectors include Medical, Biotechnology, Health Care, Pharmaceutical, Artificial Intelligence (AI). The firm invests across 36 different industry categories.
Among tracked funding rounds, Structure Therapeutics received $747.5M in a Post Ipo Equity round. Qiming Venture Partners's total known invested capital is $14.9B.
Qiming Venture Partners's average investment size is $60.5M across its portfolio of 399 companies.
Recent Qiming Venture Partners portfolio additions include Green Energy Origin, Structure Therapeutics, Sanegene Bio, Convergen, ChemLex. These companies were founded in 2020 or later.